BTI
IDXX icon

Blue Trust Inc’s Idexx Laboratories IDXX Stock Holding History

Blue Trust Inc’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Sell
150
-6
-4% -$3.37K ﹤0.01% 1142
2026
Q1 		$87.7K Buy
156
+1
+0.6% +$641 ﹤0.01% 1087
2025
Q4 		$105K Sell
155
-19
-11% -$12.9K ﹤0.01% 1039
2025
Q3 		$111K Sell
174
-3
-2% -$1.82K ﹤0.01% 1024
2025
Q2 		$94.9K Buy
177
+22
+14% +$10.5K ﹤0.01% 1069
2025
Q1 		$65.1K Sell
155
-100
-39% -$43.4K ﹤0.01% 1206
2024
Q4 		$105K Sell
255
-1,296
-84% -$568K ﹤0.01% 913
2024
Q3 		$756K Buy
1,551
+807
+108% +$392K 0.01% 337
2024
Q2 		$402K Buy
744
+429
+136% +$215K 0.01% 460
2024
Q1 		$170K Buy
315
+205
+186% +$112K ﹤0.01% 559
2023
Q4 		$49K Sell
110
-24
-18% -$11.3K ﹤0.01% 948
2023
Q3 		$67K Buy
134
+11
+9% +$5.49K ﹤0.01% 747
2023
Q2 		$62K Sell
123
-18
-13% -$8.63K ﹤0.01% 631
2023
Q1 		$57K Sell
141
-13
-8% -$6.22K ﹤0.01% 980
2022
Q4 		$50K Buy
154
+87
+130% +$33.8K ﹤0.01% 916
2022
Q3 		$23K Buy
67
+5
+8% +$1.84K ﹤0.01% 1033
2022
Q2 		$34K Buy
+62
New +$25.3K ﹤0.01% 799

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Blue Trust Inc's IDXX Position: Q2 2026 in Review

Blue Trust Inc reduced its Idexx Laboratories (IDXX) stake by 3.8% in Q2 2026, selling an estimated $3.37K and leaving 150 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Blue Trust Inc first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $756K in Q3 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Blue Trust Inc held 150 shares of Idexx Laboratories worth $79K as of Q2 2026.
  • Blue Trust Inc sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1142 holding.
  • Blue Trust Inc first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Idexx Laboratories position peaked at $756K in Q3 2024.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.